Acute Porphyria Drug Database

Monograph

N02BA11 - Diflunisal
Not porphyrinogenic
NP

Rationale
No oxidative phase in its metabolism. Four references: safe/use/use.
Chemical description
Analgesic; anti-inflammatory salisylate analogue. Eliminated in urine as glucuronide conjugate. EPI-list: safe. Australian list: safe. South African list: use. French list: use.

Similar drugs
Explore alternative drugs in similar therapeutic classes N02B / N02BA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Diflunisal · Diflunisal 250mg tablets · Dolobid · Dolobid 250mg tablets · Dolobid 500mg tablets · Novo-Diflunisal · Novo-Diflunisal 250mg tablets
Norway
Diflunisal avet
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙